Skip to Main Content

Mariya Rozenblit, MD

Medical Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Internal Medicine

Biography

Dr. Mariya Rozenblit is an Instructor of Medicine (Medical Oncology) and cares for patients with a clinical focus on breast cancer. She completed her Fellowship in Medical Oncology-Hematology at Yale, and received her medical degree from Icahn School of Medicine. In 2020, she was the recipient of the ASCO Conquer Cancer Foundation Young Investigator Award for her project, “Using single nucleotide variants of high functional importance to predict the risk of developing breast cancer in young women with high risk family history.” This award is for promising investigators to encourage and promote quality research in clinical oncology.

During her fellowship, Dr. Rozenblit, under the mentorship of Dr. Lajos Pusztai, worked to compare PD-L1 protein expression in primary tumors versus metastatic lesions in triple negative breast cancers. This manuscript was published in the Journal for ImmunoTherapy of Cancer. She also has an interest in outcomes research and under the mentorship of Dr. Sarah Mougalian, evaluated the practice patterns and efficacy of everolimus and exemestane following prior hormone therapy and CDK4/6 inhibitor use in hormone positive metastatic breast cancer.

Titles

  • Instructor of Medicine (Medical Oncology)

Education & Training

  • Internal Medicine Resident
    NYU Langone Medical Center (2018)
  • MD
    Icahn School of Medicine at Mount Sinai (2015)
  • BA
    Columbia University, Biology (2009)

Additional Information

Biography

Dr. Mariya Rozenblit is an Instructor of Medicine (Medical Oncology) and cares for patients with a clinical focus on breast cancer. She completed her Fellowship in Medical Oncology-Hematology at Yale, and received her medical degree from Icahn School of Medicine. In 2020, she was the recipient of the ASCO Conquer Cancer Foundation Young Investigator Award for her project, “Using single nucleotide variants of high functional importance to predict the risk of developing breast cancer in young women with high risk family history.” This award is for promising investigators to encourage and promote quality research in clinical oncology.

During her fellowship, Dr. Rozenblit, under the mentorship of Dr. Lajos Pusztai, worked to compare PD-L1 protein expression in primary tumors versus metastatic lesions in triple negative breast cancers. This manuscript was published in the Journal for ImmunoTherapy of Cancer. She also has an interest in outcomes research and under the mentorship of Dr. Sarah Mougalian, evaluated the practice patterns and efficacy of everolimus and exemestane following prior hormone therapy and CDK4/6 inhibitor use in hormone positive metastatic breast cancer.

Titles

  • Instructor of Medicine (Medical Oncology)

Education & Training

  • Internal Medicine Resident
    NYU Langone Medical Center (2018)
  • MD
    Icahn School of Medicine at Mount Sinai (2015)
  • BA
    Columbia University, Biology (2009)

Additional Information

  • Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Fl 4th
    New Haven, CT 06511